PTPRJ and non-Hodgkin lymphoma: Carlos Aya-Bonilla et al. have shown that PTPRJ inactivation may be a common mechanism of lymphangiogenesis in these NHL subtypes and that PTPRJ haplotypes may contribute to NHL susceptibility by affecting PTPRJ activation in such B-cell lymphomas [74].